3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
12
Multiple Myeloma
11
Lymphoma
10
Neoplasm Metastasis
9
Melanoma
7
Leukemia, Myeloid, Acute
7
Prostatic Neoplasms
6
Neuroblastoma
6
Carcinoma, Non-Small-Cell Lung
6
Wilms Tumor
5
Medulloblastoma
5
Lymphoma, Non-Hodgkin
5
Fallopian Tube Neoplasms
5
Burkitt Lymphoma
5
Breast Neoplasms
5
Triple Negative Breast Neoplasms
4
Small Cell Lung Carcinoma
4
Rhabdoid Tumor
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Osteosarcoma
4
Neuroectodermal Tumors, Primitive, Peripheral
4
Histiocytosis, Langerhans-Cell
4
Hepatoblastoma
4
Glioma
4
Ependymoma
4
Central Nervous System Neoplasms
4
Sarcoma, Kaposi
3
Sarcoma
3
Interventions
Cyclophosphamide
48
fludarabine phosphate
45
fludarabine
38
Whole-Body Irradiation
38
Mycophenolic Acid
37
Imatinib Mesylate
36
nilotinib
34
Tacrolimus
30
Busulfan
23
Cyclosporine
18
Melphalan
17
Granulocyte Colony-Stimulating Factor
17
Dasatinib
17
thymoglobulin
16
Methotrexate
16
Thiotepa
15
Peripheral Blood Stem Cell Transplantation
15
Antilymphocyte Serum
15
bosutinib
13
Filgrastim
13
Stem Cell Transplantation
11
sargramostim
8
ponatinib
8
Cytarabine
8
Cyclosporins
8
Cord Blood Stem Cell Transplantation
8
Clofarabine
8
Sirolimus
7
Rituximab
7
plerixafor
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
×
Specimen Handling
×
Clear all
No trials found.